12.07.2015 Views

roadmaps to reforming the un drug conventions - Beckley Foundation

roadmaps to reforming the un drug conventions - Beckley Foundation

roadmaps to reforming the un drug conventions - Beckley Foundation

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

4.3 Article 1(2) – definition of consumedArticle 1 [Existing text]2. For <strong>the</strong> purposes of this Convention a <strong>drug</strong> shall be regarded as “consumed” when ithas been supplied <strong>to</strong> any person or enterprise for retail distribution, medical use orscientific research; and “consumption” shall be construed accordingly.4.3.1 General comments on Article 1(2)Article 1(2) provides that ‘a <strong>drug</strong> shall be regarded as “consumed” when it has beensupplied <strong>to</strong> any person or enterprise for retail distribution, medical use or scientificresearch, or as put by <strong>the</strong> 1961 Commentary, when <strong>drug</strong>s have been transferred ‘from<strong>the</strong> manufacturing or wholesale level of <strong>the</strong> <strong>drug</strong> economy <strong>to</strong> its retail level’. 104 Thisdefinition has application in Articles 19, 20 and 21 (discussed above and in more detailbelow). Under Articles 19 and 20, Parties must provide estimates and statistical returnsin relation <strong>to</strong> <strong>drug</strong>s ‘consumed’, and <strong>un</strong>der Article 21 Parties must limit <strong>the</strong> quantities ofeach <strong>drug</strong> manufactured and imported by any co<strong>un</strong>try or terri<strong>to</strong>ry <strong>to</strong> <strong>the</strong> quantity‘consumed’ for medical and scientific purposes, in addition <strong>to</strong> <strong>the</strong> quantities used,exported, added <strong>to</strong> <strong>the</strong> s<strong>to</strong>ck and acquired for special purposes.4.3.2 Option 2 – changes <strong>to</strong> Article 1(2)Currently <strong>the</strong> definition of ‘consumed’ in Article 1(2) includes supply <strong>to</strong> any person orenterprise for retail distribution, which would cover supply for retail in non-medicaland non-scientific markets without needing <strong>to</strong> be amended. However, <strong>the</strong> definitiondoes not provide for <strong>the</strong> supply of <strong>drug</strong>s <strong>to</strong> persons for <strong>the</strong>ir personal (non-medical andnon-scientific) use. As noted above, and discussed in fur<strong>the</strong>r detail below, it is proposed<strong>un</strong>der Option 2 that <strong>the</strong> requirements for co<strong>un</strong>tries and terri<strong>to</strong>ries <strong>to</strong> furnish estimatesand statistical returns, and <strong>to</strong> prevent manufacture and import beyond <strong>the</strong>irrequirements (<strong>un</strong>der Articles 19, 20 and 21 respectively) would be extended <strong>to</strong> use of<strong>drug</strong>s o<strong>the</strong>r than for medical or scientific purposes, including personal use. To ensurethat references <strong>to</strong> quantities of <strong>drug</strong>s ‘consumed’ in Articles 19, 20 and 21 capturesquantities supplied for <strong>the</strong> personal use of <strong>the</strong> recipient, <strong>the</strong> definition of ‘consumed’ inArticle 1(2) would need <strong>to</strong> be amended <strong>to</strong> include a reference <strong>to</strong> <strong>drug</strong>s supplied <strong>to</strong> anyperson for ‘personal use’. (The changes proposed <strong>to</strong> Articles 19, 20 and 21 <strong>un</strong>der Option2 are discussed in more detail in sections 6.7, 6.8 and 6.9 below.)4.3.3 Option 2 – amendment of Article 1(2)The following amendment should be made <strong>to</strong> Article 1(2):1041961 Commentary, p. 223.83

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!